BioCentury
ARTICLE | Deals

The dealmaking at the heart of the NewCo boom

Formed with Hummingbird assets, $187M, Callio brings trend to Singapore

March 3, 2025 2:07 PM UTC

The latest NewCo deal — built on ADCs from Hummingbird and a nine-digit venture round from a global syndicate of 10 investors — expands the model to Singapore and adds momentum to a trend already moving at galloping speed, with 11 biotechs formed in little over a year.

The partnership, which was announced as the BioCentury-BayHelix East-West Summit began in Singapore on Monday, adds two more prominent Western VCs in Frazier Life Sciences and Jeito Capital and a pair of leading investors from Singapore, ClavystBio and EDBI, to the cohort of firms building companies via the model. That group of investors now stands at 63...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article